# Dabigatran Versus Conventional Treatment for Prevention of Silent Cerebral Infarct in Atrial Fibrillation Associated With Valvular Disease

Study · id `cardio:ct-nct02982850` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02982850](<https://clinicaltrials.gov/study/NCT02982850>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02982850

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems; Valve and congenital heart disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

## Technical summary

Registry record NCT02982850. Randomized; no masking; primary purpose treatment. Start 2016-12 (registry gives no type); primary completion 2020-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 120 participants (enrolled count; ClinicalTrials.gov record NCT02982850, source copy `cardio:ctgov-nct02982850-2021-01-13`, retrieved 2026-10-26)
- Start date: 2016-12 (registry gives no type) (ClinicalTrials.gov record NCT02982850, source copy `cardio:ctgov-nct02982850-2021-01-13`, retrieved 2026-10-26)
- Primary completion: 2020-10 (actual) (ClinicalTrials.gov record NCT02982850, source copy `cardio:ctgov-nct02982850-2021-01-13`, retrieved 2026-10-26)
- Completion: 2020-10 (actual) (ClinicalTrials.gov record NCT02982850, source copy `cardio:ctgov-nct02982850-2021-01-13`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT02982850, source copy `cardio:ctgov-nct02982850-2021-01-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02982850-2021-01-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Dabigatran Versus Conventional Treatment for Prevention of Silent Cerebral Infarct in Atrial Fibrillation Associated With Valvular Disease
- Acronym: DECISIVE
- Condition: Atrial Fibrillation
- Condition: Valve Heart Disease
- Intervention (Drug): Dabigatran
- Intervention (Drug): Acetylsalicylic acid
- Intervention (Drug): Warfarin
- Lead sponsor: Asan Medical Center
- Lead sponsor class: OTHER
- Collaborator: Boehringer Ingelheim
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry intervention name matches this record: Dabigatran (`cardio:dabigatran`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry intervention name matches this record: Warfarin (`core:warfarin`)
- Registry lists this organization as the lead sponsor: Asan Medical Center (`cardio:org-asan-medical-center`)
- Registry lists this organization as a collaborator: Boehringer Ingelheim (`cardio:boehringer-ingelheim`)

## Provenance

Content hash: 76c170d3906db206bf8f6171643bc800d6e394eda6afa29fd9afb74d88713aa9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
